Rhabdomyolysis during Therapy with Daptomycin
- 15 June 2006
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 42 (12) , e108-e110
Abstract
The use of daptomycin has been associated with an elevation in creatine phosphokinase level, with a reported incidence of 2.8% in phase III clinical trials. Published case reports have documented the presence of myopathy in patients who received daptomycin; however, there have been no previously reported cases of rhabdomyolysis in animals or humans to date. We describe a case of rhabdomyolysis during therapy with daptomycin.Keywords
This publication has 7 references indexed in Scilit:
- Severe myopathy and possible hepatotoxicity related to daptomycinJournal of Antimicrobial Chemotherapy, 2005
- Muscle Pain Associated with DaptomycinAnnals of Pharmacotherapy, 2004
- The Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-Structure InfectionsClinical Infectious Diseases, 2004
- A Review of RhabdomyolysisDimensions of Critical Care Nursing, 2004
- Acute rhabdomyolysis as a complication of cytarabine chemotherapy for acute myeloid leukemia: Case report and review of literatureAmerican Journal of Hematology, 2002
- Once-Daily Dosing in Dogs Optimizes Daptomycin SafetyAntimicrobial Agents and Chemotherapy, 2000
- Bacterial sepsis-induced rhabdomyolysisIntensive Care Medicine, 1999